Aesthetics & botox stocks
미용·보톡스
What are Aesthetics & botox stocks in Korea?
The Aesthetics & botox theme on jonbur groups 14 Korean stocks listed on KOSPI and KOSDAQ, worth ₩21T in total. On Oct 28, 2026 the group moved up 2.41% (weighted by market value); the largest members are APR, PharmaResearch, Hugel.
Key facts
- Stocks
- 14
- Total market value
- ₩21T
- Day's move
- +2.41%
- As of
- Oct 28, 2026
- Largest members
- APR, PharmaResearch, Hugel
Earnings tracker · 4Q 2025
Past quarter
Combined, for the companies that have reported, vs the same quarter a year ago
| Company | Reported | Revenue | vs a year ago | Operating profit | vs a year ago | vs last quarter | Op. margin |
|---|---|---|---|---|---|---|---|
| APR | Mar 23 | ₩548B | +124.2% | ₩130B | +228.3% | +35.5% | 23.8%16.3% |
| PharmaResearch | Mar 19 | ₩143B | +39.1% | ₩52B | +54.1% | −16.1% | 36.2%32.7% |
| Hugel | Mar 20 | ₩119B | +21.3% | ₩58B | +24.5% | +22.0% | 48.5%47.3% |
| Classys | Mar 23 | ₩93B | +25.6% | ₩51B | +43.0% | +36.1% | 54.8%48.1% |
| Daewoong Pharma | Mar 18 | ₩397B | +7.9% | ₩43B | +12.0% | −23.8% | 10.9%10.5% |
| L&C Bio | Mar 24 | ₩25B | +29.2% | ₩2B | Turned to profit | −32.5% | 7.9%−3.3% |
| Medy-Tox | Mar 19 | ₩61B | +10.0% | −₩3.7B | Turned to loss | Turned to loss | −6.1%1.7% |
| WON Tech | Mar 19 | ₩46B | +26.0% | ₩12B | −11.2% | +60.9% | 26.4%37.5% |
| Huons Global | Mar 23 | ₩225B | +10.9% | ₩19B | −26.2% | −4.7% | 8.6%13.0% |
| Humedix | Mar 20 | ₩46B | +22.8% | ₩11B | +9.3% | +24.0% | 24.2%27.2% |
| Jetema | Mar 20 | ₩20B | +7.1% | ₩1.2B | Turned to profit | +15.2% | 5.8%−0.1% |
| Laserssel | Mar 23 | ₩2.3B | +1,414.2% | −₩3.8B | Bigger loss | Bigger loss | −164.8%−1,981.5% |
| Hironic | Mar 20 | ₩8.4B | −11.5% | ₩1.7B | Turned to profit | +253.7% | 20.3%−66.9% |
| 287410 | Not yet | ||||||
| RecensMedical | Not yet | ||||||
Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.
Upcoming events
Korea events calendar →Technical breadth
After the close on Oct 28, 2026- Above 20-day average
- 23.5%
- Above 60-day average
- 5.9%
- RSI above 70
- 0%
- RSI below 30
- 17.6%
- 52-week highs
- 0
- 52-week lows
- 2
Index gauge · Short term
Bearish
1 bullish, 1 neutral, 7 bearish
Index gauge · Medium term
Bearish
0 bullish, 0 neutral, 8 bearish
Technical read
The Aesthetics & botox theme comprises 17 Korean stocks, and only 23.5% of them trade above their 20-day averages while just 5.9% sit above their 60-day averages. No members are at 52-week highs, two are at 52-week lows, and the lowest member RSI is 17.6 with no member showing an RSI at the high extreme. The equal-weighted theme index is labeled bearish on both short- and medium-term readings, with an RSI of 32 and the index positioned below its cloud.
Written by AI from the indicator values above. Not advice.
Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Credit & macro
No notable credit, ELS or macro events for these companies in the last 30 days.
Aesthetics & botox
+1.55%미용·보톡스
The Aesthetics & Botox theme groups Korean listed companies that develop, manufacture, or distribute botulinum toxin injectables, dermal fillers, and other non-surgical cosmetic treatments, along with related medical aesthetic devices and clinic-linked businesses. Korean investors often cluster these firms together because the country has a large domestic and export market for such products, and many of them share similar regulatory approval processes, overseas licensing deals, and sales patterns tied to global cosmetic demand.
14 companies · 10 up · 0 flat · 4 down
- Traded value
- ₩124B
- Value vs 20-day average
- 0.67×
- Top gainer
- Laserssel +6.49%
- Largest company
- APR ₩11T
Companies in this theme
| Company | Price | Daily | Traded value | Market cap | NPS |
|---|---|---|---|---|---|
APR278470 · KOSPI | ₩289,000 | +3.96% | ₩53B | ₩11T | 7.86% |
PharmaResearch214450 · KOSDAQ | ₩228,500 | −1.30% | ₩44B | ₩2.4T | 7.14% |
Hugel145020 · KOSDAQ | ₩181,500 | +1.17% | ₩4.8B | ₩2.3T | 2.29% |
Classys214150 · KOSDAQ | ₩27,000 | +1.89% | ₩7.7B | ₩1.8T | 2.06% |
Daewoong Pharma069620 · KOSPI | ₩99,900 | +0.81% | ₩2.5B | ₩1.2T | 10.30% |
L&C Bio290650 · KOSDAQ | ₩24,950 | +4.83% | ₩4.8B | ₩673B | 1.28% |
Medy-Tox086900 · KOSDAQ | ₩65,800 | −2.52% | ₩903M | ₩480B | 1.44% |
WON Tech336570 · KOSDAQ | ₩3,940 | +1.68% | ₩1.7B | ₩352B | — |
Huons Global084110 · KOSDAQ | ₩21,500 | −2.05% | ₩563M | ₩272B | 0.64% |
Humedix200670 · KOSDAQ | ₩23,700 | +3.27% | ₩334M | ₩262B | 1.03% |
Jetema216080 · KOSDAQ | ₩5,960 | −1.16% | ₩479M | ₩222B | 0.01% |
Laserssel412350 · KOSDAQ | ₩6,400 | +6.49% | ₩1.9B | ₩93B | — |
Hironic149980 · KOSDAQ | ₩3,950 | +2.20% | ₩45M | ₩68B | 0.20% |
RecensMedical394420 · KOSDAQ | ₩5,600 | +2.38% | ₩461M | ₩62B | — |
Source: KRX statistical information